Key result
The aldose reductase 2 inhibitor BF-5m reduces high glucose-induced cardiac QT interval prolongation in experimental models by restoring antioxidant defenses and KCNQ1/KCNE1 expression.
Answers are grounded in this paper and cite their sources.
In vitro data require rigorous validation before any clinical consideration; leaves open relevance to human cardiovascular disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Maria Consiglia Trotta (2018) conducted a review in Hyperglycemia-induced Long QT interval prolongation. BF-5m was evaluated. The aldose reductase 2 inhibitor BF-5m reduces high glucose-induced cardiac QT interval prolongation in experimental models by restoring antioxidant defenses and KCNQ1/KCNE1 expression.
Synapse has enriched 10 related papers. Consider them for comparative context: